Harbour Investments, Inc. Pacira Bio Sciences, Inc. Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 50 shares of PCRX stock, worth $861. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 30
66.67%
Holding current value
$861
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PCRX
# of Institutions
273Shares Held
48.6MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$138 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$87.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$37.3 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$35.6 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$32.8 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $790M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...